Thank you for your interest in research at UTMB! Taking part in research is one way to be part of tomorrow’s healthcare discoveries. UTMB is always looking for volunteers just like you so that our researchers can better understand how to prevent, diagnose, and treat diseases. Everyone is needed. Both healthy volunteers and people with health conditions can help us answer important questions that impact the health of our communities. Ready to start searching for a study to be involved with?

  • Enter a health condition or leave it blank if you are looking to join any study as a healthy volunteer
  • Enter your gender and age
  • Click “View Results”
  • Click on the study titles for information
  • Click on the “Contact/Details” tab to get information for contacting the study team


65 matching studies

Sponsor Condition of Interest
The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and1
The University of Texas Medical Branch, Galveston Brain Injuries
The aim of this study is to characterize the microbiome of patients undergoing post-acute residential neurorehabilitation compared to community controls and to determine if a dietary fiber, Inulin, can create a shift in the microbiome leading to changes in fatigue and cognition. expand

The aim of this study is to characterize the microbiome of patients undergoing post-acute residential neurorehabilitation compared to community controls and to determine if a dietary fiber, Inulin, can create a shift in the microbiome leading to changes in fatigue and cognition.

Type: Interventional

Start Date: Mar 2025

open study
The Gut Microbiome and Immunotherapy Response in Solid Cancers
The University of Texas Medical Branch, Galveston Cancer
The aim of this study is characterize the gastrointestinal microbiomes of patient with solid cancer undergoing standard of care treatment with programmed cell death protein 1 (PD-1) /programmed cell death ligand (PD-L1) blockade. expand

The aim of this study is characterize the gastrointestinal microbiomes of patient with solid cancer undergoing standard of care treatment with programmed cell death protein 1 (PD-1) /programmed cell death ligand (PD-L1) blockade.

Type: Observational

Start Date: Jun 2023

open study
Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With1
Tanabe Pharma America, Inc. EPP XLP
To evaluate the long-term safety and tolerability of oral dersimelagon. expand

To evaluate the long-term safety and tolerability of oral dersimelagon.

Type: Interventional

Start Date: Aug 2021

open study
Wearable Echolocation Aids Using Parametric Sound
The University of Texas Medical Branch, Galveston Low Vision
The objective of this study is to study a novel device designed to aid patients with impaired vision to safely navigate their environment. Subjects for this study will be individuals with normal vision, either with or without correction. The subjects will wear a device to simulate impaired vision a1 expand

The objective of this study is to study a novel device designed to aid patients with impaired vision to safely navigate their environment. Subjects for this study will be individuals with normal vision, either with or without correction. The subjects will wear a device to simulate impaired vision and will be asked to walk a path with randomly placed obstacles during two trials. One of the trials will consist of the subject wearing the simulator alone. The other trial will consist of the subject wearing the simulator and the study device. The study device is designed to be worn by the study subject and will emit tones to indicate obstacles in the environment as the subject walks on the path with random obstacles. The tones will indicate that there is an obstacle in the individual's path and will increase in intensity as the subject moves closer to the object.Invest

Type: Interventional

Start Date: Feb 2025

open study